<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="molecules-26-00487-t002" ref-type="table">Table 2</xref> shows the effect of the prolonged administration of PCS (25 and 50 mg/kg b. w.) on ASAT and ALAT serum levels. A decrease was noted for the groups treated with PCS when compared to the diabetic control group (
 <italic>p</italic> &lt; 0.001), which exhibited a significant elevation in the activities of those enzymes compared to the normal control group (
 <italic>p</italic> &lt; 0.001). This elevation is attributed to a loss of functional integrity of the hepatocellular membranes and a cellular leakage. 
</p>
